COLL vs MPC · P/E 17, rev $181.9M vs P/E 16, rev $138.86B
Collegium Pharmaceutical Inc (COLL) versus Marathon Petroleum Corp (MPC) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Marathon Petroleum Corp (MPC) is a oil & gas refining & marketing company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported MPC revenue for 2024-12-31 was $138.86B. Net income was $5.07B. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
Not investment advice. Open the COLL and MPC stock pages for the full models.
Not investment advice.